5g64: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "5g64" [edit=sysop:move=sysop] |
No edit summary |
||
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
The entry 5g64 is ON HOLD | The entry 5g64 is ON HOLD until Paper Publication | ||
Authors: Davies, A.M., Allan, E.G., Keeble, A.H., Cossins, B.P., Mitropoulou, A.N., Pang, M.O.Y., Ceska, T., Beavil, A.J., Craggs, G., Westwood, M., Henry, A.J., McDonnell, J.M., Sutton, B.J. | Authors: Davies, A.M., Allan, E.G., Keeble, A.H., Delgado, J., Cossins, B.P., Mitropoulou, A.N., Pang, M.O.Y., Ceska, T., Beavil, A.J., Craggs, G., Westwood, M., Henry, A.J., McDonnell, J.M., Sutton, B.J. | ||
Description: The complex between human IgE-Fc and two anti-IgE Fab fragments | Description: The complex between human IgE-Fc and two anti-IgE Fab fragments | ||
[[Category: Unreleased Structures]] | [[Category: Unreleased Structures]] | ||
[[Category: Delgado, J]] | |||
[[Category: Henry, A.J]] | [[Category: Henry, A.J]] | ||
[[Category: Pang, M.O.Y]] | [[Category: Pang, M.O.Y]] | ||
[[Category: Cossins, B.P]] | [[Category: Cossins, B.P]] | ||
[[Category: Allan, E.G]] | [[Category: Allan, E.G]] | ||
[[Category: Keeble, A.H]] | |||
[[Category: Sutton, B.J]] | [[Category: Sutton, B.J]] | ||
[[Category: Mitropoulou, A.N]] | [[Category: Mitropoulou, A.N]] | ||
[[Category: Davies, A.M]] | [[Category: Davies, A.M]] | ||
[[Category: Mcdonnell, J.M]] | [[Category: Mcdonnell, J.M]] | ||
[[Category: Westwood, M]] | |||
[[Category: Ceska, T]] | |||
[[Category: Craggs, G]] | [[Category: Craggs, G]] | ||
[[Category: Beavil, A.J]] | [[Category: Beavil, A.J]] | ||
Revision as of 08:52, 9 March 2017
Unreleased structure
The entry 5g64 is ON HOLD until Paper Publication
Authors: Davies, A.M., Allan, E.G., Keeble, A.H., Delgado, J., Cossins, B.P., Mitropoulou, A.N., Pang, M.O.Y., Ceska, T., Beavil, A.J., Craggs, G., Westwood, M., Henry, A.J., McDonnell, J.M., Sutton, B.J.
Description: The complex between human IgE-Fc and two anti-IgE Fab fragments
